EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms

INTRODUCTION: Avoiding phagocytic cells and reducing off-target toxicity are the primary hurdles in the clinical application of nanoparticles containing therapeutics. For overcoming these errors, in this study, nanoparticles expressing CD47 proteins inhibiting the phagocytic attack of immune cells w...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Moon Jung, Choi, Kang Chan, Lee, Do Hyun, Jeong, Hwa Yeon, Kang, Seong Jae, Kim, Min Woo, Jeong, In Ho, You, Young Myoung, Lee, Jin Suk, Lee, Yeon Kyung, Im, Chan Su, Park, Yong Serk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270928/
https://www.ncbi.nlm.nih.gov/pubmed/35818431
http://dx.doi.org/10.2147/NSA.S352038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270928/
https://www.ncbi.nlm.nih.gov/pubmed/35818431
http://dx.doi.org/10.2147/NSA.S352038

Ejemplares similares